US Bancorp DE Takes $133,000 Position in Grail, Inc. (NASDAQ:GRAL)

US Bancorp DE acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the 4th quarter, Holdings Channel reports. The firm acquired 7,477 shares of the company’s stock, valued at approximately $133,000.

Other institutional investors have also recently made changes to their positions in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Grail during the fourth quarter valued at about $244,000. Moloney Securities Asset Management LLC acquired a new position in shares of Grail during the fourth quarter valued at about $559,000. Wesbanco Bank Inc. acquired a new position in shares of Grail during the fourth quarter valued at about $523,000. Rhumbline Advisers acquired a new position in shares of Grail during the fourth quarter valued at about $456,000. Finally, Slow Capital Inc. acquired a new stake in shares of Grail in the 4th quarter worth about $2,379,000.

Insider Buying and Selling at Grail

In other news, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the transaction, the chief executive officer now directly owns 828,662 shares of the company’s stock, valued at $25,862,541.02. This represents a 0.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,550 shares of company stock worth $360,436.

Analyst Ratings Changes

Separately, Morgan Stanley started coverage on shares of Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price on the stock.

Grail Trading Up 10.5 %

NASDAQ:GRAL opened at $29.74 on Monday. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The firm has a 50-day moving average price of $31.81 and a two-hundred day moving average price of $21.39.

Grail (NASDAQ:GRAL) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analysts’ expectations of $35.33 million. Equities analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.